Thomas J. Metzner

2.4k total citations
17 papers, 459 citations indexed

About

Thomas J. Metzner is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Thomas J. Metzner has authored 17 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Thomas J. Metzner's work include Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (3 papers). Thomas J. Metzner is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Cancer Genomics and Diagnostics (5 papers) and Cancer Cells and Metastasis (3 papers). Thomas J. Metzner collaborates with scholars based in United States, Germany and United Kingdom. Thomas J. Metzner's co-authors include Joseph C. Liao, Sanjiv S. Gambhir, John T. Leppert, Ryan M. Davis, Dharati R. Trivedi, Bernhard Kiss, Matt van de Rijn, Debashis Sahoo, Timothy Chang and Robert V. Rouse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Thomas J. Metzner

17 papers receiving 452 citations

Peers

Countries citing papers authored by Thomas J. Metzner

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Metzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Metzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Metzner more than expected).

Fields of papers citing papers by Thomas J. Metzner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Metzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Metzner. The network helps show where Thomas J. Metzner may publish in the future.

Co-authorship network of co-authors of Thomas J. Metzner

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Metzner. A scholar is included among the top collaborators of Thomas J. Metzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Metzner. Thomas J. Metzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Detecting androgen receptor (AR), AR variant 7 (AR-V7), prostate-specific membrane antigen (PSMA), and prostate-specific antigen (PSA) gene expression in CTCs and plasma exosome-derived cfRNA in patients with metastatic castration-resistant prostate cancer (mCRPC) by integrating the VTX-1 CTC isolation system with the QIAGEN AdnaTest 2024 ·BMC Cancer ·(unknown), Meghah Vuppalapaty, Christian R. Hoerner, Colin P. Bergstrom, (unknown), (unknown), James Che, (unknown), (unknown), Sean Liu, Thomas J. Metzner, (unknown), (unknown), Markus Sprenger‐Haussels, Martin Schlumpberger, John T. Leppert, Siegfried Hauch, Elodie Sollier, Alice C. Fan	5
2	Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS) 2021 ·Urologic Oncology Seminars and Original Investigations ·(unknown), I‐Chun Thomas, (unknown), Kristopher Kapphahn, Thomas J. Metzner, (unknown), Christian R. Hoerner, Alice C. Fan, Viraj A. Master, Glenn M. Chertow, James D. Brooks, Chirag J. Patel, Manisha Desai, John T. Leppert	1
3	Nanoparticle-enabled innate immune stimulation activates endogenous tumor-infiltrating T cells with broad antigen specificities 2021 ·Proceedings of the National Academy of Sciences ·Qian Yin, Wong Yu, Caitlin L. Grzeskowiak, Jing Li, Huang Huang, Jing Guo, Liang Chen, Feng Wang, Fan Zhao, Lotta von Boehmer, Thomas J. Metzner, John T. Leppert, Yueh‐hsiu Chien, Calvin J. Kuo, Mark M. Davis	20
4	The m ⁶ A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor 2020 ·Proceedings of the National Academy of Sciences ·Yiren Xiao, Kaushik N. Thakkar, Hongjuan Zhao, James P. Broughton, (unknown), José A. Seoane, Anh N. Diep, Thomas J. Metzner, Rie von Eyben, David L. Dill, James D. Brooks, Christina Curtis, John T. Leppert, Jiangbin Ye, Donna M. Peehl, Amato J. Giaccia, Subarna Sinha, Erinn B. Rankin	88
5	Development of a DNA Methylation–Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma 2020 ·JCO Precision Oncology ·Kevin Brennan, Thomas J. Metzner, Chia‐Sui Kao, Charles Massie, Grant D. Stewart, Robert W. Haile, James D. Brooks, Megan P. Hitchins, John T. Leppert, Olivier Gevaert	11
6	Optical biopsy of penile cancer with in vivo confocal laser endomicroscopy 2019 ·Urologic Oncology Seminars and Original Investigations ·Eugene Shkolyar, (unknown), Kathleen E. Mach, Dharati R. Trivedi, Dimitar V. Zlatev, Timothy Chang, Thomas J. Metzner, John T. Leppert, Chia‐Sui Kao, Joseph C. Liao	4
7	The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review 2019 ·European Urology Focus ·(unknown), Thomas J. Metzner, John T. Leppert	43
8	Early Changes in CT Perfusion Parameters: Primary Renal Carcinoma Versus Metastases After Treatment with Targeted Therapy 2019 ·Cancers ·Alice C. Fan, Vandana Sundaram, Aya Kino, Heiko Schmiedeskamp, Thomas J. Metzner, Aya Kamaya	3
9	Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma 2018 ·European Urology Oncology ·Christian R. Hoerner, Rustin Massoudi, Thomas J. Metzner, Laurel Stell, (unknown), Christina S. Kong, (unknown), James D. Brooks, Chiara Sabatti, John T. Leppert, Alice C. Fan	2
10	Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular Phenotype 2018 ·ACS Nano ·Ryan M. Davis, Bernhard Kiss, Dharati R. Trivedi, Thomas J. Metzner, Joseph C. Liao, Sanjiv S. Gambhir	96
11	Preclinical Testing of a Combination Stone Basket and Ureteral Balloon to Extract Ureteral Stones 2017 ·Journal of Endourology ·Rustin Massoudi, Thomas J. Metzner, (unknown), Tin C. Ngo, Rajesh Shinghal, John T. Leppert	1
12	Monitoring Neutropenia for Cancer Patients at the Point of Care 2017 ·Small Methods ·Hakan Inan, James L. Kingsley, Mehmet Ozgün Ozen, H. Cumhur Tekin, Christian R. Hoerner, (unknown), Thomas J. Metzner, (unknown), Naside Gözde Durmus, Mehmet Özsöz, Heather A. Wakelee, Alice C. Fan, Erkan Tüzel, Utkan Demirci	4
13	Endoscopic molecular imaging of human bladder cancer using a CD47 antibody 2014 ·Science Translational Medicine ·Ying Pan, Jens-Peter Volkmer, Kathleen E. Mach, Robert V. Rouse, Jen-Jane Liu, Debashis Sahoo, Timothy Chang, Thomas J. Metzner, Lei Kang, Matt van de Rijn, Eila C. Skinner, Sanjiv S. Gambhir, Irving L. Weissman, Joseph C. Liao	125
14	Abstract 2283: Nano-scale proteomic profiles of response to targeted therapy in patients with RCC. 2013 ·Cancer Research ·Alice C. Fan, John T. Leppert, (unknown), Liwen Xu, Thomas J. Metzner, Emelyn H. Shroff, (unknown), (unknown), James D. Brooks, Lauren C. Harshman, Chiara Sabatti, Sandhya Srinivas, Dean W. Felsher	1
15	Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line 2012 ·Physical Biology ·Daniel C. Lazar, Edward H. Cho, Madelyn Luttgen, Thomas J. Metzner, Maria Uson, (unknown), Mitchell E. Gross, Peter Kühn	53
16	Non-enrichment-based method for analysis of androgen receptor expression in circulating tumor cells (CTCs) in patients with metastatic castrate-resistant prostate cancer. 2012 ·Journal of Clinical Oncology ·Mitchell E. Gross, Daniel C. Lazar, Edward H. Cho, Madelyn Luttgen, Thomas J. Metzner, Maria Uson, (unknown), Peter Kühn	1
17	Abstract 3619: The absence of cleaved caspase-3 in circulating tumor cells detected using a non-enrichment-based assay 2012 ·Cancer Research ·Thomas J. Metzner, Kelly Bethel, Edward H. Cho, Madelyn Luttgen, Daniel C. Lazar, Maria Uson, Jorge J. Nieva, Lyudmila Bazhenova, Anand Kolatkar, Peter Kühn	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact